Loading
Latest filing published 20 Nov 2023 for Acer Therapeutics Inc.. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Chris Schelling is a declared insider of Acer Therapeutics Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 29 November 2022 to 17 November 2023.
Purchases make up the whole of the open-market record (1 purchase, €967k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 20 November 2023: a transaction, in Acer Therapeutics Inc. The latest purchase dates back some time: it was published 1,417 days ago, on 1 December 2022. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations